Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer

NCT00170677 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Topotecan
DRUG: Topotecan

Sponsor

North Eastern German Society of Gynaecological Oncology